US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
EP1000084A4
(en)
|
1997-07-08 |
2003-03-26 |
Human Genome Sciences Inc |
123 human secreted proteins
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
EP1086223B1
(en)
|
1998-06-01 |
2009-07-29 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
CN1387538A
(en)
|
1999-01-15 |
2002-12-25 |
比奥根公司 |
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
|
US7291719B2
(en)
|
2000-07-25 |
2007-11-06 |
Genentech, Inc. |
PRO4332 antibodies
|
EP1666490A3
(en)
*
|
2000-07-25 |
2006-11-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2002243444A1
(en)
|
2000-10-31 |
2002-06-24 |
Diadexus, Inc. |
Compositions and methods relating to colon specific genes and proteins
|
US20020111302A1
(en)
*
|
2000-11-30 |
2002-08-15 |
Y. Tom Tang |
Novel nucleic acids and polypeptides
|
WO2002083921A2
(en)
*
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US7164007B2
(en)
|
2001-06-20 |
2007-01-16 |
Genentech, Inc. |
Anti-PR020044 antibodies
|
ES2537074T3
(en)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Nucleic acid and corresponding protein called STEAP-1 useful in the treatment and detection of cancer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
CA2463596A1
(en)
|
2001-10-12 |
2003-04-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Method of screening cell death inhibitor
|
CN103536916B
(en)
|
2002-04-09 |
2016-08-17 |
比奥根Ma公司 |
For the method treating TWEAK associated conditions
|
AU2003900747A0
(en)
*
|
2003-02-18 |
2003-03-06 |
Garvan Institute Of Medical Research |
Diagnosis and treatment of pancreatic cancer
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP1842920B2
(en)
*
|
2003-09-23 |
2017-06-21 |
University Of North Carolina At Chapel Hill |
Cells coexpressing vitamin K reductase and vitamin K dependent protein and use thereof to improve the productivity of said vitamin K dependent protein
|
JP4777251B2
(en)
*
|
2003-10-14 |
2011-09-21 |
バクスター・インターナショナル・インコーポレイテッド |
Therapeutic target of vitamin K epoxide reductase complex subunit 1VKORC1, coumarin and its derivatives
|
US20070269421A1
(en)
*
|
2004-02-03 |
2007-11-22 |
Bayer Healthcare Ag |
Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
BRPI0418766B8
(en)
|
2004-04-22 |
2021-05-25 |
Agensys Inc |
antibody or fragment thereof, vector, pharmaceutical composition, assay and method for detecting the presence of step-1 protein, as well as a method for delivering a cytotoxic agent or a diagnostic agent
|
US8759305B2
(en)
*
|
2004-09-01 |
2014-06-24 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of innate immune responses and autoimmunity
|
JP2008512100A
(en)
*
|
2004-09-07 |
2008-04-24 |
テレソン インスティテュート フォー チャイルド ヘルス リサーチ |
Method for diagnosis and / or prediction of onset of allergic diseases
|
US20100003241A1
(en)
*
|
2004-09-07 |
2010-01-07 |
Patrick Holt |
Agents for treatment or prevention of an allergic disorder
|
EP1859277A4
(en)
|
2005-02-17 |
2010-03-17 |
Biogen Idec Inc |
Treating neurological disorders
|
DK1853700T3
(en)
|
2005-02-28 |
2013-01-07 |
Baxter Int |
RECOMBINANT CO-EXPRESSION OF VITAMIN-K-EPOXID REDUCTASE UNIT 1 TO IMPROVE VITAMIN-K-DEPENDED PROTEIN EXPRESSION
|
CA2601574C
(en)
|
2005-03-15 |
2014-12-02 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
CA2607697C
(en)
|
2005-05-10 |
2015-01-06 |
Biogen Idec Ma Inc. |
Treating and evaluating inflammatory disorders
|
WO2006138219A2
(en)
|
2005-06-13 |
2006-12-28 |
Biogen Idec Ma Inc. |
Methods of diagnosis / prognosis of inflammatory conditions
|
WO2007025347A1
(en)
*
|
2005-09-01 |
2007-03-08 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Prophylactic and therapeutic agents and uses therefor
|
GB0521488D0
(en)
*
|
2005-10-21 |
2005-11-30 |
Ares Trading Sa |
Integral membrane protein
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
PT2502938E
(en)
|
2006-10-27 |
2015-06-05 |
Genentech Inc |
Antibodies and immunoconjugates and uses therefor
|
CN101636179B
(en)
|
2006-11-07 |
2012-10-10 |
默沙东公司 |
Antagonists of pcsk9
|
US8093222B2
(en)
|
2006-11-27 |
2012-01-10 |
Isis Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia
|
CA2680832A1
(en)
|
2007-03-27 |
2008-10-02 |
Merck & Co., Inc. |
Method for detecting autoprocessed, secreted pcsk9
|
JOP20080381B1
(en)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)
|
AU2008317261B2
(en)
|
2007-10-26 |
2015-04-09 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
WO2009070350A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Siemens Healthcare Diagnostics Inc. |
Adiponectin receptor fragments and methods of use
|
AR070315A1
(en)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
ANTIBODIES 1B20 ANTAGONISTS OF PCSK9
|
AR070316A1
(en)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
PCSK9 ANTAGONISTS (SUBTILISINE-KEXINA TYPE 9 PROPROTEIN)
|
WO2010068526A1
(en)
|
2008-12-12 |
2010-06-17 |
Merck Sharp & Dohme Corp. |
Pcsk9 immunoassay
|
CN102639150A
(en)
|
2009-10-30 |
2012-08-15 |
默沙东公司 |
AX213 and AX132 PCSK9 antagonists and variants
|
EP2493505A4
(en)
|
2009-10-30 |
2013-06-12 |
Merck Sharp & Dohme |
Ax1 and ax189 pcsk9 antagonists and variants
|
KR101810593B1
(en)
|
2010-06-16 |
2017-12-22 |
다이나박스 테크놀로지 코퍼레이션 |
Methods of treatment using tlr7 and/or tlr9 inhibitors
|
US8871737B2
(en)
|
2010-09-22 |
2014-10-28 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
US9631002B2
(en)
|
2010-12-21 |
2017-04-25 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin K-dependent proteins
|
WO2013096680A1
(en)
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
EP2828277A1
(en)
|
2012-03-21 |
2015-01-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9034332B1
(en)
|
2014-07-15 |
2015-05-19 |
Kymab Limited |
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
US8986691B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
US9023359B1
(en)
|
2014-07-15 |
2015-05-05 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US8883157B1
(en)
|
2013-12-17 |
2014-11-11 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US8945560B1
(en)
|
2014-07-15 |
2015-02-03 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
US9045548B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
US9051378B1
(en)
|
2014-07-15 |
2015-06-09 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
US9682218B2
(en)
|
2013-12-23 |
2017-06-20 |
Carefusion 2200, Inc. |
Pleurodesis device and method
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US9150660B1
(en)
|
2014-07-15 |
2015-10-06 |
Kymab Limited |
Precision Medicine by targeting human NAV1.8 variants for treatment of pain
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
GB2605925B
(en)
|
2016-12-23 |
2023-02-22 |
Harvard College |
Gene editing of PCSK9
|
ES2955852T3
(en)
|
2017-04-03 |
2023-12-07 |
Hoffmann La Roche |
STEAP-1 binding antibodies
|
EP3641951B1
(en)
|
2017-06-22 |
2023-09-20 |
The Procter & Gamble Company |
Films including a water-soluble layer and a vapor-deposited organic coating
|
WO2018237213A1
(en)
*
|
2017-06-22 |
2018-12-27 |
The Procter & Gamble Company |
Films including a water-soluble layer and a vapor-deposited inorganic coating
|